Malaria Ag Rapid Testing Market Outlook:
Malaria Ag Rapid Testing Market size was over USD 38.35 billion in 2025 and is poised to exceed USD 61.29 billion by 2035, growing at over 4.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of malaria ag rapid testing is estimated at USD 40.01 billion.
This market is poised to rise on account of the growing prevalence of malaria. According to the World Health Organization, in comparison to 244 million cases in 2021, there were a total of 249 million cases of malaria in 2022, according to the most recent World Malaria Report. The predicted number of malaria deaths stood to 608 000 in 2022 compared to 610 000 in 2021. Hence, the market demand for malaria ag rapid testing is poised to rise.
Furthermore, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae are the four different types of malaria parasites that affect humans. However, it is estimated that more different types of malaria are set to become prevalent in the coming years. Therefore, the need for malaria ag rapid testing is poised to surge in the coming years.
Key Malaria Ag Rapid Testing Market Insights Summary:
Regional Highlights:
- North America industry is predicted to capture a 30% revenue share by 2035, impelled by rising travelers returning to the region.
- The malaria Ag rapid testing market in Europe is expected to expand steadily over the forecast period, owing to rigorous vaccine launches and ongoing research.
Segment Insights:
- The hospital chain pharmacy segment in the malaria ag rapid testing market is projected to account for a 40% share by 2035, owing to growth in the number of hospitals.
- The dipstick segment is estimated to hold a 60% share by 2035, propelled by their portability and ability to improve diagnostic accuracy.
Key Growth Trends:
- Surge in Adoption of Latest Technology
- Rise in Government Initiatives for Awareness Regarding Malaria
Major Challenges:
- Lack of Awareness Regarding Malaria Among People
- Lack of Efficiency of Test
Key Players: Amcor plc, Norwex, BASF SE, 3V Incorporation, Evonik Industries AG, JNC Corporation, KANSAI PAINT CO., LTD., Daio Paper Co., Ltd, Lion Co., Ltd., KANEKA CORPORATION.
Global Malaria Ag Rapid Testing Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 38.35 billion
- 2026 Market Size: USD 40.01 billion
- Projected Market Size: USD 61.29 billion by 2035
- Growth Forecasts: 4.8% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (30% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, India, China, Germany, United Kingdom
- Emerging Countries: India, China, Brazil, Mexico, Thailand
Last updated on : 25 February, 2026
Malaria Ag Rapid Testing Market - Growth Drivers and Challenges
Growth Drivers
- Surge in Adoption of Latest Technology - After the outbreak of the pandemic various technologies proved its importance in various sectors. However, healthcare was greatly benefited from the same. One of the technologies is IoT. The main issue is to determine the kind of parasite (strains) that cause malaria in individuals, or more specifically, identifying the presence of malaria. At present, many nations with high malaria rates have either nonexistent or very inadequate surveillance systems. Furthermore, many cannot afford it even if it were available. As a result, the demand for IoT in malaria testing is rising. With the Internet of things, every person who is a health volunteer in a tiny village might simply collect a blood sample and get an answer concerning the presence of the malaria parasite without needing any understanding of detecting parasites.
- Rise in Government Initiatives for Awareness Regarding Malaria - A vital factor in the successful eradication of malaria was health promotion and education. Programmes to raise awareness of malaria have an important effect on health promotion as they improve health-related behaviors and raise awareness of the disease while additionally promoting social support and inter-sectoral cooperation. For instance, Mission Zero Malaria, which has been launched in collaboration with Malaria No More as an implementation partner, is in line with India's 2030 elimination of malaria goal. Its objective is to raise health awareness and encourage the adoption of desired behavior changes within the community, health system, and government bodies in the region.
- Extreme Weather Events to Increase the Prevalence of Malaria - Severe weather conditions including heat waves and flooding can also have an immediate effect on the burden of disease and its spread. There is growing evidence connecting the spread of malaria to climate change, and certain experts predict that unless considerable steps are taken to combat climate change, malaria transmission will continue to rise globally. For instance, Pakistan experienced catastrophic flooding in 2022, leading to the number of malaria infections rising five-fold. Concurrently, it is believed that additional environmental modifications, such as deforestation, may influence mosquito dispersal patterns and, consequently, the transmission of diseases transmitted by mosquitoes.
Challenges
- Lack of Awareness Regarding Malaria Among People
- Lack of Efficiency of Test
- Lack of Adoption of Technology - The lack of clear demand for improved goods and tiny profit margins make it difficult to provide incentives to encourage malaria RDT innovation. The latest developments in malaria RDT are mostly supported by donors, and they move slowly. Prequalified testing is particularly critical for scenarios where HRP2/3 deletions have occurred. Manufacturers lack access to trustworthy information about the rate at which deletions will spread, the nations that will probably need new testing or the methods that procurers will use to handle these tests (e.g., pricing, sourcing based on product differentiation). Hence, the market is set to be hindered over the forecast period.
Malaria Ag Rapid Testing Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
4.8% |
|
Base Year Market Size (2025) |
USD 38.35 billion |
|
Forecast Year Market Size (2035) |
USD 61.29 billion |
|
Regional Scope |
|
Malaria Ag Rapid Testing Market Segmentation:
Distribution Channel (Drugstore, Retail Pharmacy, Hospital Chain Pharmacy, Online Pharmacy)
The hospital chain pharmacy segment in the malaria ag rapid testing market is set to gather the highest share of about 40% during the forecast period. This growth is set to be influenced by growth in number of hospitals. The number of hospitals worldwide as of 2021 is estimated to be over 164,000. Hospitals serve a vital role in the struggle over malaria, given their ability to deal with a wide range of medical ailments, particularly severe cases of the illness. Since RDTs are dependable and precise, patients receive swift and accurate diagnoses in hospital settings. This is why they are preferred. In addition, hospitals frequently act as referral hubs for patients from different areas seeking care, so having access to quick and accurate diagnostic tests is crucial. Furthermore, the widespread use of hospitals and the crucial role that clinics play in treating and diagnosing malaria indicate a comprehensive approach to the disease. The collaborative effort between these healthcare settings emphasizes the need of customized diagnostic approaches for a range of end users and shows promise for more successful malaria control.
Product Type (Dipsticks, Cassette)
Malaria ag rapid testing market from the dipstick segment is estimated to gather the highest share of about 60% during the forecast period. This could be since, researchers came to the judgment that, if nonspecialized laboratories are engaged, dipsticks offer the potential to improve the specific accuracy of the diagnosis of P. falciparum malaria based on the specificity and sensitivity achieved. Furthermore, since they are portable, dipstick instruments provide on-site testing for the identification of tampered specimens. This major advantage has led to an abundance of commercially available devices. Moreover, the cost of the dipstick is relevantly low which adds to its demand. These typically entail attaching chemically treated pads to plastic strips, each pad serving as an assay for a distinct characteristic of the object. Since they are portable, dipstick instruments provide on-site testing for the identification of tampered specimens. This major advantage has led to an abundance of commercially available devices. These typically entail attaching chemically treated pads to plastic strips, each pad serving as an assay for a distinct characteristic of the object.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Distribution Channel |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Malaria Ag Rapid Testing Market - Regional Analysis
North American Market Forecast
North America industry is predicted to account for largest revenue share of 30% by 2035. This growth is set to be dominated by rising travelers returning to North America. Furthermore, with about 45% of US corporate travelers doing more trips than they did prior to the epidemic, business travel is returning. However, this has further led to an increase in malaria cases. Most of the people in North America visit regions such as the Middle East & Africa which is the hotspots for malaria prevalence. Hence, these travelers return back with the infection hence boosting the malaria rate. Every year, travel to malaria-endemic regions including sub-Saharan Africa, parts of South America, and Southeast Asia is linked to between 1,999 and 2,500 cases of malaria in the country; nevertheless, over 8 locally transmitted cases this year have been reported by individuals who haven't recently visited these regions. There were about 6 instances reported in Florida and one in each of Maryland and Texas. Hence, it has also been estimated that this region has recorded its first homegrown malaria cases. Therefore, the market for malaria ag rapid testing market is set to rise in this region.
European Market Analysis
The malaria ag rapid testing market in Europe is also expected to experience significant growth over the forecast period. Fifty years after being eradicated, malaria remains a serious health threat in Europe. Furthermore, there has been rigorous launch of vaccines in this region by various key players and number of researches has taken place in order to eradicate completely. As a result, this market is poised to grow in this region.
Malaria Ag Rapid Testing Market Players:
- Wyss Institute
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis AG
- Alere, Inc.
- Nectar Lifesciences Ltd.
- Teco Diagnostics
- Xiamen Boson Biotech Co. Ltd.
- HWTAi BioTec
- Arkray Inc.
- CTK Biotech Inc.
- Biosynex SA
Recent Developments
- A multidisciplinary research team led by James Collins, Ph.D., a member of the Wyss Core Faculty at the Massachusetts Institute of Technology (MIT) and Harvard's Wyss Institute for Biologically Inspired Engineering, and put together by clinical fellow Rose Lee, M.D., M.S.P.H., along with Pollock and Dvorin, has developed a highly sensitive diagnostic assay that can be used in the field to identify DNA sequences from all Plasmodium species in both symptomatic and asymptomatic cases of malaria. With the help of the CRISPR-based SHERLOCK system and an optimised 10-minute quick sample preparation technique, the novel malaria diagnostic approach allows for extremely sensitive and specific Plasmodium identification in just 60 minutes using straightforward reporter devices. The publication is in PNAS.
- In response to the growing concern of resistance to existing malaria treatments1,2, Novartis and MMV have decided to move ganaplacide/lumefantrine solid dispersion formulation (SDF) into Phase 3 development for the treatment of individuals suffering from acute, uncomplicated Plasmodium falciparum malaria.
- Report ID: 5547
- Published Date: Feb 25, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Malaria Ag Rapid Testing Market Report Scope
Free Sample includes current and historical market size, growth trends, regional charts & tables, company profiles, segment-wise forecasts, and more.
Connect with our Expert
Copyright @ 2026 Research Nester. All Rights Reserved.
